Diabetes, Vol 45, Issue 2 127-133, Copyright © 1996 by American Diabetes Association

ARTICLES

A subtractive cloning approach to the identification of mRNAs specifically expressed in pancreatic beta-cells

PI Neophytou, EM Muir and JC Hutton
Department of Clinical Biochemistry, University of Cambridge, Addenbrooke's Hospital, U.K.

A polymerase chain reaction-based subtractive hybridization procedure was applied to cDNAs prepared from mouse insulinoma (beta TC3) and glucagonoma (alpha TC2) cell lines to construct a library of cDNAs that are highly expressed in pancreatic beta-cells. An analysis of 555 randomly chosen clones in the library showed that 80 were derived from abundant mRNAs and were accounted for by 29 distinct sequences. Of these, 17 were identical or homologous to known mammalian cDNAs or expressed sequence tags. Genes known to be highly expressed in beta-cells were represented at a high frequency, namely insulin (15 of 80 clones), islet amyloid polypeptide (8 of 80 clones), proinsulin convertase 1 (6 of 80 clones), and neuropeptide Y (2 of 80 clones). Many of the novel cDNA sequences that were highly represented in the library showed a relative specificity to beta-cells compared with other tissues, including glucagonoma, liver, kidney, brain, 3T3 fibroblasts, and AtT20 corticotrophs, and warrant further investigation. When combined with functional or immunological screening procedures, the approach will be useful for the isolation of beta-cell-specific molecules for immunological and genetic investigations of beta-cell function and pathology.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. P. Olcott, J. Tian, V. Walker, H. Dang, B. Middleton, L. Adorini, L. Washburn, and D. L. Kaufman Antigen-Based Therapies Using Ignored Determinants of {beta} Cell Antigens Can More Effectively Inhibit Late-Stage Autoimmune Disease in Diabetes-Prone Mice J. Immunol., August 1, 2005; 175(3): 1991 - 1999. [Abstract] [Full Text] [PDF]

				C. Frigeri, C. C. Martin, C. A. Svitek, J. K. Oeser, J. C. Hutton, M. Gannon, and R. M. O'Brien The Proximal Islet-Specific Glucose-6-Phosphatase Catalytic Subunit-Related Protein Autoantigen Promoter Is Sufficient to Initiate but not Maintain Transgene Expression in Mouse Islets in Vivo Diabetes, July 1, 2004; 53(7): 1754 - 1764. [Abstract] [Full Text] [PDF]

				J. C. Hutton and G. S. Eisenbarth A pancreatic {beta}-cell-specific homolog of glucose-6-phosphatase emerges as a major target of cell-mediated autoimmunity in diabetes PNAS, July 22, 2003; 100(15): 8626 - 8628. [Full Text] [PDF]

				E. Jaikaran, G Marcon, L Levesque, P. George-Hyslop, P. Fraser, and A Clark Localisation of presenilin 2 in human and rodent pancreatic islet beta-cells; Met239Val presenilin 2 variant is not associated with diabetes in man J. Cell Sci., January 7, 1999; 112(13): 2137 - 2144. [Abstract] [PDF]

				J. Wang, L. Shen, H. Najafi, J. Kolberg, F. M. Matschinsky, M. Urdea, and M. German Regulation of insulin preRNA splicing by glucose PNAS, April 29, 1997; 94(9): 4360 - 4365. [Abstract] [Full Text] [PDF]

				H. Niwa, L. C. Harrison, H. J. DeAizpurua, and D. S. Cram Identification of Pancreatic {beta} Cell-Related Genes by Representational Difference Analysis Endocrinology, April 1, 1997; 138(4): 1419 - 1426. [Abstract] [Full Text] [PDF]

				F. Atouf, P. Czernichow, and R. Scharfmann Expression of Neuronal Traits in Pancreatic Beta Cells. IMPLICATION OF NEURON-RESTRICTIVE SILENCING FACTOR/REPRESSOR ELEMENT SILENCING TRANSCRIPTION FACTOR, A NEURON-RESTRICTIVE SILENCER J. Biol. Chem., January 17, 1997; 272(3): 1929 - 1934. [Abstract] [Full Text] [PDF]